TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
ZYBT

Zhengye Biotechnology Holding Limited

Healthcare · Drug Manufacturers - Specialty & Generic

1.20$ +4.5% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ZYBT
Line item Q4 22 Q2 23 Q4 23 Q2 24 Q4 24 Q2 25 Q3 25 Q4 25 Q1 26
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
41.2% 42.2% 41.1% 38.9% 36.0% 36.0% 31.5% 31.5% 31.5%
1.9% 4.6% 3.0% 1.5% 3.8% 3.8% 11.5% 11.5% 11.5%
1.9% 4.6% 3.3% 1.7% – 4.1% 11.9% – 11.9%
25.8% 24.1% 19.9% 18.8% 12.1% 17.9% 4.2% 4.2% 4.2%
10.7% 10.5% 11.7% 13.4% 11.8% 11.8% 9.0% 9.0% 9.0%
3.7% 3.5% 3.3% 5.0% 4.6% 4.6% 12.5% 12.5% 12.5%
31.3% 36.6% 32.1% 28.3% 28.5% 28.5% 29.7% 29.7% 29.7%
29.3% 34.5% 30.1% 28.2% 27.6% 27.6% 27.6% 27.6% 27.6%
10.6% 15.5% 16.0% 17.9% – 16.6% 15.1% – 15.1%
15.3% 9.5% 9.1% 8.5% 8.7% 8.7% 10.1% 10.1% 10.1%
– 1.9% 2.0% – 1.0% 1.0% – 2.0% –
57.1% 50.9% 54.6% 57.8% 57.6% 57.6% 57.2% 57.2% 57.2%
12.7% 6.0% 7.7% 9.7% 9.8% 9.8% 2.5% -5.0% -5.0%
– – 9.4% 9.7% 9.6% 9.6% 10.9% 10.9% 10.9%

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?